Prevalence and Molecular Identification of Human Schistosomiasis
ConditionSchistosomiasis
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorAssiut University
About this trial
Schistosomiasis remains one of the most important parasitic diseases of public health concern, particularly in developing countries including Egypt. It is caused by a trematode worm (blood flukes) of the genus Schistosoma
Eligibility criteria
Qualifiers
Patients aged ≥ 5 years of both sexes attending Assiut Governorate hospitals during the study period.
Patients clinically suspected of having schistosomiasis (urinary and/or intestinal) or referred for parasitological examination.
Individuals (or guardians, in case of minors) who provide written informed consent.
Patients willing to provide the required biological samples (urine and/or stool).
Disqualifiers
Patients Received praziquantel within the last 3 months before sample collection
Patients with incomplete clinical or epidemiological data.
Patients refusing participation or sample collection.
Improperly collected, contaminated, or insufficient samples.
Trial design
Treatments tested in this trial
- Molecular phylogenetic and haplotype analysis
Treatment groups
359 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov